+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Neurorehabilitation Device Market 2019-2028

  • ID: 5187998
  • Report
  • November 2020
  • Region: Global
  • 189 pages
  • Triton Market Research

FEATURED COMPANIES

  • Abbott Laboratories
  • Bionik Laboratories Corp
  • Ectron Limited
  • Hokoma Ag
  • Kinova
  • Neurostyle Pte Ltd
  • MORE
MARKET OUTLOOK

The publisher, in its research report, estimates the global neurorehabilitation device market to proliferate with a CAGR of 14.52% in the forecast years 2019-2028.

The growing prevalence of neurological diseases is the major driving force behind the growth of this market. Further, the rise in the elderly population and the growing adoption of neurorehabilitation wearables & robotics are aiding this growth. In addition, technological advancements and the rising occurrence of neurological disorders in developing nations are creating major opportunities for growth. However, the lack of a skilled workforce to cater to people with neurological diseases and the high cost of treatment are hindering the market growth. In addition, stringent regulations by the government are creating hurdles in the path of growth.

REGIONAL OUTLOOK

The global market for neurorehabilitation device spans across the regions of North America, the Asia-Pacific, Latin America, Europe, and the Middle East and Africa.

The Asia-Pacific region is expected to showcase the fastest growth rate in the global market in the forecast period. The APAC market is being driven mainly by the growth in the elderly population in the region. For instance, Japan has the highest number of older adults in the region. In addition, the government & private organizations are taking initiatives to spread awareness about neurological conditions. Further, they are also helping patients with such conditions to lead normal lives. The growing prevalence of neurological diseases, especially the older age group, is a major factor fueling market growth in the Asia-Pacific.

COMPETITIVE OUTLOOK

The competitive players in the neurorehabilitation device market are Neurostyle Pte Ltd, Biometrics Ltd, Ectron Limited, Medtronic Inc, Kinova, Abbott Laboratories, Tyromotion GmbH, Bioxtreme, Saebo, Bionik Laboratories Corp, Kinestica, Hokoma AG, Reha Technology AG, Ekso Bionics Holdings Inc, and Helius Medical Technologies.

Abbott Laboratories is a pharmaceutical company developing, manufacturing, and marketing a broad line of healthcare products. The company offers medical devices, diagnostic systems, neuromodulation devices, generic pharmaceuticals, and pediatric & adult nutritional products. It sells its products under multiple brand names, such as HeartMate, Oxepa, Cell-Dyn, Similac, Duspatal, FreeStyle, FlexAbility, Heptral, and Alinity. Proclaim Elite Recharge-free SCS System, Prodigy MRI Implantable Pulse Generator, and Infinity DBS IPG are some of its neurorehabilitation devices. The company was founded in 1888, and operates in several nations, including the US, Germany, China, Japan, the Netherlands, India, and Switzerland.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Bionik Laboratories Corp
  • Ectron Limited
  • Hokoma Ag
  • Kinova
  • Neurostyle Pte Ltd
  • MORE
1. Global Neurorehabilitation Device Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Model
2.2.1. Threat of New Entrants
2.2.2. Threat of Substitute Products
2.2.3. Bargaining Power of Buyers
2.2.4. Bargaining Power of Suppliers
2.2.5. Competitive Rivalry
2.3. Supply Chain Outlook
2.4. Impact of Coronavirus on Neurorehabilitation Device Market
2.5. Etymology of Neurorehabilitation Device
2.6. Key Impact Analysis
2.7. Market Attractiveness Index
2.8. Key Insights
2.9. Market Drivers
2.9.1. Rise in Geriatric Population
2.9.2. Growing Emergence of Neurorehabilitation Wearables and Robotics
2.9.3. Rising Prevalence of Neurological Diseases
2.10. Market Restraints
2.10.1. Lack of Skilled Workforce to Treat and Manage Neurological Diseases
2.10.2. High Cost of Treatment
2.11. Market Opportunities
2.11.1. Advancements in Technology
2.11.2. Rising Incidence of Neurological Disorders in Developing Economies
2.12. Market Challenges
2.12.1. Stringent Government Regulations

3. Neurehabilitation Device Market Outlook - by Product
3.1. Neuro-Robotic System
3.2. Brain-Computer Interface
3.3. Wearable Device
3.4. Non-Invasive Stimulator
3.5. Other Products

4. Neurehabilitation Device Market Outlook - by Application
4.1. Stroke
4.2. Cerebral Palsy
4.3. Parkinson's Disease
4.4. Multiple Sclerosis
4.5. Other Applications

5. Neurehabilitation Device Market Outlook - by End-User
5.1. Hospital/Clinic
5.2. Research Institute
5.3. Cognitive Care Center
5.4. Other End-User

6. Neurehabilitation Device Market - Regional Outlook
6.1. North America
6.1.1. Market by Product
6.1.2. Market by Application
6.1.3. Market by End-User
6.1.4. Country Analysis
6.1.4.1. United States
6.1.4.2. Canada
6.2. Europe
6.2.1. Market by Product
6.2.2. Market by Application
6.2.3. Market by End-User
6.2.4. Country Analysis
6.2.4.1. Germany
6.2.4.2. France
6.2.4.3. United Kingdom
6.2.4.4. Italy
6.2.4.5. Russia
6.2.4.6. Spain
6.2.4.7. Rest of Europe
6.3. Asia-Pacific
6.3.1. Market by Product
6.3.2. Market by Application
6.3.3. Market by End-User
6.3.4. Country Analysis
6.3.4.1. China
6.3.4.2. Japan
6.3.4.3. Australia & New Zealand
6.3.4.4. India
6.3.4.5. South Korea
6.3.4.6. Asean Countries
6.3.4.7. Rest of APAC
6.4. Latin America
6.4.1. Market by Product
6.4.2. Market by Application
6.4.3. Market by End-User
6.4.4. Country Analysis
6.4.4.1. Mexico
6.4.4.2. Brazil
6.4.4.3. Rest of Latin America
6.5. Middle East and Africa
6.5.1. Market by Product
6.5.2. Market by Application
6.5.3. Market by End-User
6.5.4. Country Analysis
6.5.4.1. Saudi Arabia
6.5.4.2. United Arab Emirates
6.5.4.3. Turkey
6.5.4.4. South Africa
6.5.4.5. Rest of Middle East & Africa

7. Company Profiles
7.1. Bionik Laboratories Corp
7.2. Tyromotion Gmbh
7.3. Bioxtreme
7.4. Ectron Limited
7.5. Kinova
7.6. Abbott Laboratories
7.7. Biometrics Ltd
7.8. Reha Technology Ag
7.9. Medtronic Inc
7.10. Helius Medical Technologies
7.11. Hokoma Ag
7.12. Kinestica
7.13. Saebo
7.14. Neurostyle Pte Ltd
7.15. Ekso Bionics Holdings Inc

8. Research Methodology & Scope
8.1. Research Scope & Deliverables
8.1.1. Objectives of Study
8.1.2. Scope of Study
8.2. Sources of Data
8.2.1. Primary Data Sources
8.2.2. Secondary Data Sources
8.3. Research Methodology
8.3.1. Evaluation of Proposed Market
8.3.2. Identification of Data Sources
8.3.3. Assessment of Market Determinants
8.3.4. Data Collection
8.3.5. Data Validation & Analysis

List of Tables
Table 1 Global Neurorehabilitation Device Market, by Region, 2019-2028 (In $ Million)
Table 2 Global Neurorehabilitation Device Market, by Product, 2019-2028 (In $ Million)
Table 3 Global Neurorehabilitation Device Market, by Application, 2019-2028 (In $ Million)
Table 4 Global Neurorehabilitation Device Market, by End-User, 2019-2028 (In $ Million)
Table 5 Global Neurorehabilitation Device Market, by Region, 2019-2028 (In $ Million)
Table 6 North America Neurorehabilitation Device Market, by Product, 2019-2028 (In $ Million)
Table 7 North America Neurorehabilitation Device Market, by Application, 2019-2028 (In $ Million)
Table 8 North America Neurorehabilitation Device Market, by End-User, 2019-2028 (In $ Million)
Table 9 North America Neurorehabilitation Device Market, by Country, 2019-2028 (In $ Million)
Table 10 Europe Neurorehabilitation Device Market, by Product, 2019-2028 (In $ Million)
Table 11 Europe Neurorehabilitation Device Market, by Application, 2019-2028 (In $ Million)
Table 12 Europe Neurorehabilitation Device Market, by End-User, 2019-2028 (In $ Million)
Table 13 Europe Neurorehabilitation Device Market, by Country, 2019-2028 (In $ Million)
Table 14 Asia-Pacific Neurorehabilitation Device Market, by Product, 2019-2028 (In $ Million)
Table 15 Asia-Pacific Neurorehabilitation Device Market, by Application, 2019-2028 (In $ Million)
Table 16 Asia-Pacific Neurorehabilitation Device Market, by End-User, 2019-2028 (In $ Million)
Table 17 Asia-Pacific Neurorehabilitation Device Market, by Country, Historic Year 2016-2019 (In $ Million)
Table 18 Asia-Pacific Neurorehabilitation Device Market, by Country, 2019-2028 (In $ Million)
Table 19 Latin America Neurorehabilitation Device Market, by Product, 2019-2028 (In $ Million)
Table 20 Latin America Neurorehabilitation Device Market, by Application, 2019-2028 (In $ Million)
Table 21 Latin America Neurorehabilitation Device Market, by End-User, 2019-2028 (In $ Million)
Table 22 Latin America Neurorehabilitation Device Market, by Country, 2019-2028 (In $ Million)
Table 23 Middle East and Africa Neurorehabilitation Device Market, by Product, 2019-2028 (In $ Million)
Table 24 Middle East and Africa Neurorehabilitation Device Market, by Application, 2019-2028 (In $ Million)
Table 25 Middle East and Africa Neurorehabilitation Device Market, by End-User, 2019-2028 (In $ Million)
Table 26 Middle East and Africa Neurorehabilitation Device Market, by Country, 2019-2028 (In $ Million)

List of Figures
Figure 1 Global Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 2 Supply Chain Outlook for Neurorehabilitation Device Market
Figure 3 Etymology of Neurorehabilitation Device Market
Figure 4 Prevalence of Alzheimer's Disease in the United States, Age Wise, 2019 (%)
Figure 5 Number of Geriatric Population, by Region, (In Million)
Figure 6 Surging Prevalence of Parkinson's Disease Globally (In Million)
Figure 7 Global Neurorehabilitation Device Market, by Neuro-Robotic System, 2019-2028 (In $ Million)
Figure 8 Global Neurorehabilitation Device Market, by Brain-Computer Interface, 2019-2028 (In $ Million)
Figure 9 Global Neurorehabilitation Device Market, by Wearable Device, 2019-2028 (In $ Million)
Figure 10 Global Neurorehabilitation Device Market, by Non-Invasive Stimulator, 2019-2028 (In $ Million)
Figure 11 Global Neurorehabilitation Device Market By, Other Products, 2019-2028 (In $ Million)
Figure 12 Global Neurorehabilitation Device Market, by Stroke, 2019-2028 (In $ Million)
Figure 13 Global Neurorehabilitation Device Market, by Cerebral Palsy, 2019-2028 (In $ Million)
Figure 14 Global Neurorehabilitation Device Market, by Parkinson's Disease, 2019-2028 (In $ Million)
Figure 15 Global Neurorehabilitation Device Market, by Multiple Sclerosis, 2019-2028 (In $ Million)
Figure 16 Global Neurorehabilitation Device Market, by Other Applications, 2019-2028 (In $ Million)
Figure 17 Global Neurorehabilitation Device Market, by Hospital/Clinic, 2019-2028 (In $ Million)
Figure 18 Global Neurorehabilitation Device Market, by Research Institute, 2019-2028 (In $ Million)
Figure 19 Global Neurorehabilitation Device Market, by Cognitive Care Center, 2019-2028 (In $ Million)
Figure 20 Global Neurorehabilitation Device Market, by Other End-User, 2019-2028 (In $ Million)
Figure 21 United States Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 22 Canada Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 23 Germany Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 24 France Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 25 United Kingdom Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 26 Italy Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 27 Russia Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 28 Spain Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 29 Rest of Europe Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 30 Asia-Pacific Neurorehabilitation Device Market, Country Outlook, 2019 & 2028 (In %)
Figure 31 China Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 32 Japan Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 33 Australia & New Zealand Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 34 India Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 35 South Korea Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 36 Asean Countries Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 37 Rest of APAC Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 38 Mexico Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 39 Brazil Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 40 Rest of Latin America Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 41 Saudi Arabia Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 42 United Arab Emirates Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 43 Turkey Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 44 South Africa Neurorehabilitation Device Market 2019-2028 (In $ Million)
Figure 45 Rest of Middle East & Africa Neurorehabilitation Device Market 2019-2028 (In $ Million)
Note: Product cover images may vary from those shown
  • Bionik Laboratories Corp
  • Tyromotion Gmbh
  • Bioxtreme
  • Ectron Limited
  • Kinova
  • Abbott Laboratories
  • Biometrics Ltd
  • Reha Technology Ag
  • Medtronic Inc
  • Helius Medical Technologies
  • Hokoma Ag
  • Kinestica
  • Saebo
  • Neurostyle Pte Ltd
  • Ekso Bionics Holdings Inc
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll